drugset / Trial / NCT03450109
A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer
Non-randomizedParallel-groupOpen-labelOther
Summary
A phase I, randomized, open-label and active-control study to assess the PK, PD and safety profiles of LY01005 versus goserelin comparator to be conducted in the USA.
Timeline
- Start
- 2017-12-22
- Primary completion
- 2018-10-15
- Completion
- 2018-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Goserelin | Other / unclassified | 3.6 mg | Subcutaneous |
| Subject | LY01005 | Unknown | 3.6 mg | Intramuscular |